Vanessa Mendonça

Prof. Vanessa Mendonça

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Expert Review of Respiratory Medicine
Verified
Journal Article
Closed access
MMMaria Eduarda Melo-Oliveira
Maria Eduarda Melo-Oliveira
Danúbia Sá-CaputoDanúbia Sá-Caputo
Danúbia Sá-Caputo
JBJosé Alexandre Bachur
José Alexandre Bachur
Laisa Liane Paineiras-DomingosLaisa Liane Paineiras-Domingos
Laisa Liane Paineiras-Domingos
Anelise SonzaAnelise Sonza
Anelise Sonza
Mario Bernardo-FilhoMario Bernardo-Filho
Mario Bernardo-Filho
Considering the relevance of the Quality of life (QoL) and the consequences of the 2019 new coronavirus disease (COVID-19) due to the social distancing, this systematic review aimed to summarize ef...

1 August 2008 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
VMVanessa Mendonça
Vanessa Mendonça
RCRosane Dias Costa
Rosane Dias Costa
GMGustavo Eustáquio Brito Alvim De Melo
Gustavo Eustáquio Brito Alvim De Melo
CACarlos Maurício Antunes
Carlos Maurício Antunes
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
A hanseníase é doença crônica infecciosa que se caracteriza por apresentar formas clínicas contrastantes, que são dependentes da interação do bacilo com a resposta imune do hospedeiro. O estudo dos processos imunológicos torna-se fundamental para o entendimento dos mecanismos envolvidos na apresentação e no desenvolvimento da doença. Neste artigo, é revisada a imunopatogênese da hanseníase.

1 January 2022 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
EFEduardo Augusto Barbosa Figueiredo
Eduardo Augusto Barbosa Figueiredo
WSWhesley Tanor Silva
Whesley Tanor Silva
STSabrina Pinheiro Tsopanoglou
Sabrina Pinheiro Tsopanoglou
DVDébora Fernandes de Melo Vitorino
Débora Fernandes de Melo Vitorino
LOLuciano Fonseca Lemos Oliveira
Luciano Fonseca Lemos Oliveira
HCHenrique Silveira Costa
Henrique Silveira Costa
Symptoms in post-COVID-19 patients who require hospitalization can persist for months, significantly affecting their health-related quality of life (HRQoL). Thus, the present study aimed to discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization. An electronic search was performed in the MEDLINE, EMBASE, CINAHL, Web of Science, LILACS, and Scopus databases, without date and language restrictions, until July 2021. Twenty-four articles were included in the analysis. It seems that HRQoL partially improved soon after hospital discharge, although the negative impact on HRQoL may persist for months. The physical and mental aspects are affected because patients report pain, discomfort, anxiety, and depression. The HRQoL of COVID-19 infected patients was worse than that of uninfected patients. Additionally, HRQoL seemed worse in patients admitted to the intensive care unit than in those who remained in the ward. Improvements in HRQoL after hospital discharge are independent of imaging improvement, and there seems to be no association between HRQoL after hospital discharge and disease severity on hospital admission. Many factors have been identified as determinants of HRQoL, with women and advanced age being the most related to worse HRQOL, followed by the duration of invasive mechanical ventilation and the need for intensive care. Other factors included the presence and number of comorbidities, lower forced vital capacity, high body mass index, smoking history, undergraduate education, and unemployment. In conclusion, these findings may aid in clinical management and should be considered in the aftercare of patients.

1 April 2021 in Ciencia & Saude Coletiva
Verified
Journal Article
Open access
PDF file
Luiz Felipe Ferreira de SouzaLuiz Felipe Ferreira de Souza
Luiz Felipe Ferreira de Souza
Laisa Liane Paineiras-DomingosLaisa Liane Paineiras-Domingos
Laisa Liane Paineiras-Domingos
MMMaria Eduarda de Souza Melo-Oliveira
Maria Eduarda de Souza Melo-Oliveira
JPJuliana Pessanha-Freitas
Juliana Pessanha-Freitas
EMEloá Moreira-Marconi
Eloá Moreira-Marconi
Mario Bernardo-FilhoMario Bernardo-Filho
Mario Bernardo-Filho
This article aims to evaluate the sleep quality in individuals during the COVID-19 pandemic by Pittsburgh Sleep Quality Index (PSQI). Searches were conducted in the PubMed, Embase, Web of Science, and PEDro databases, on May 22, 2020. In the publications, 208 articles were found and, considering the eligibility criteria, 10 articles were included at the end, showing the effects on sleep quality during the pandemic, in populations hospitalized, quarantined, and in frontline health professionals. The PSQI measured sleep disorders and a higher score indicated poor sleep quality. Nine articles were classified with evidence level IV and one as level III-2. Eight studies present a “serious” risk of bias and two in “moderate”. The studies investigated different populations and described the results as “poor” sleep quality, considering the PSQI on quarantined individuals and frontline health professionals as the most committed. A poor sleep quality was found in the populations evaluated in the selected publications, probably, due to the COVID-19 to contribute as a risk factor for mental health. Psychological interventions must be made to minimize the consequences through social support and social capital.

27 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LSLuana Aparecida Soares
Luana Aparecida Soares
LLLiliana Pereira Lima
Liliana Pereira Lima
APAna Caroline Negreiros Prates
Ana Caroline Negreiros Prates
AAArthur Arrieiro
Arthur Arrieiro
LTLeonardo Augusto da Costa Teixeira
Leonardo Augusto da Costa Teixeira
Ana Cristina Rodrigues LacerdaAna Cristina Rodrigues Lacerda
Ana Cristina Rodrigues Lacerda
Certain cut-off points for sarcopenia screening and diagnosis are arbitrary and based on European populations, with normative references often obtained from healthy young adults. Although respiratory skeletal muscle strength tests represent low-cost clinical measures commonly performed in clinical practice by health professionals, a gap remains regarding whether respiratory skeletal muscle strength tests are adequate and sensitive measures for sarcopenia screening. This study aimed to verify the value of handgrip and respiratory muscle strength as possible discriminators to identify sarcopenia and to establish cut-off points for sarcopenia screening in community-dwelling, Brazilian women. In a cross-sectional study, 154 community-dwelling, Brazilian women (65–96 years) were assessed for appendicular skeletal muscle mass, handgrip (HGS), and respiratory muscular strength, including maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). The data were analyzed using the ROC curve and the Youden Index determined cut-off points. Statistical significance was set at 5%. 88 participants (57%) were sarcopenic. MEP (OR 0.98 [95%CI 0.97, 1.00], p = 0.023) and HGS (OR 0.82 [95% CI 0.75, 0.90], p < 0.001) were independent factors for sarcopenia in older. The optimal cut-off points for identifying sarcopenia were ≤ 77 cmH2O for MEP (AUC = 0.72), and ≤ 20 kg for HGS (AUC = 0.80). Simple muscular strength tests, including HGS and MEP, may be considered in the identification of sarcopenia in older, community-dwelling, Brazilian women. Future work is still needed to assess external validation of the proposed cut-offs before the clinical application.

7 February 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LLLiliana Pereira Lima
Liliana Pereira Lima
HLHércules Ribeiro Leite
Hércules Ribeiro Leite
MMMariana Aguiar de Matos
Mariana Aguiar de Matos
CNCamila Danielle Cunha Neves
Camila Danielle Cunha Neves
VLVanessa Kelly da Silva Lage
Vanessa Kelly da Silva Lage
VMVanessa Mendonça
Vanessa Mendonça
Preliminary studies have showed that the Incremental Shuttle Walking Test (ISWT) is a maximal test, however comparison between ISWT with the cardiopulmonary exercise test (CEPT) has not yet performed in the healthy woman population. Furthermore, there is no regression equation available in the current literature to predict oxygen peak consumption (VO2 peak). Thus, this study aimed to compare the ISWT with CEPT and to develop an equation to predict peak oxygen uptake (VO2 peak) in healthy women participants. First, the VO2 peak, respiratory exchange ratio (R peak), heart rate max (HR max) and percentage of predicted HR max (% predicted HR max) were evaluated in the CEPT and ISWT (n = 40). Then, an equation was developed to predict the VO2 peak (n = 54) and its validation was performed (n = 20). There were no significant differences between the ISWT and CEPT of VO2 peak, HR max and % predicted HR max values (P>0.05), except for R peak measure in the ISWT (1.22 ± 0.13) and CEPT (1.18 ± 0.1) (P = 0.022). Therefore, both tests showed a moderate positive correlation of VO2 peak (r = 0.51; P = 0.0007), HR max (r = 0.65; P<0.0001) and R peak (r = 0.55; P = 0.0002) and the Bland-Altman analysis showed agreement of VO2 peak (bias = -0.14). The distance walked on ISWT and age explained 36.3% (R2 Adjusted = 0.363) of the variance in VO2 peak. The equation developed was VO2 peak (predicted) = 19.793 + (0.02 x distance walked)—(0.236 x age). There was no statistically significant difference between the VO2 peak measured directly and the predicted, and the Bland-Altman analysis showed agreement (bias = 1.5 ml/kg/min). ISWT is a maximal test showing similar results compared to the CEPT, and the predicted equation was valid and applicable for VO2 peak assessing in young adult healthy women.